New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;PFE;DUF;CG;HLF;CALM From The Last 14 Days
Check below for free stories on BMY;PFE;DUF;CG;HLF;CALM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 28, 2014
08:10 EDTCGOrtho-Clinical Diagnostics, Astute Medical to develope acute kidney injury tests
Subscribe for More Information
06:36 EDTPFEPfizer downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
06:34 EDTCALMCal-Maine Foods is 'cautiously optimistic' about good start to FY15
Subscribe for More Information
06:34 EDTCALMCal-Maine Foods reports Q4 total dozens eggs produced 195.63M
Reports Q4 total dozens eggs sold 249.44M
06:33 EDTCALMCal-Maine Foods reports Q4 EPS $1.30, consensus $1.15
Subscribe for More Information
05:55 EDTPFEStocks with implied volatility movement; IGT PFE
Subscribe for More Information
July 25, 2014
16:01 EDTCALMCal-Maine Foods announces new JV for specialty egg sales in Arizona
Cal-Maine Foods announced the company has entered into a new joint venture for specialty egg sales with Hickmanís Egg Ranch. Based in Buckeye, Arizona, a suburb of Phoenix in western Maricopa County, Hickmanís Egg Ranch has been family-owned and operated since 1944. With processing operations located in Arizona, Colorado and California, and capacity for approximately 6M laying hens, Hickmanís Egg Ranch ranks among the top twenty family egg farms in the United States. Pursuant to this transaction, the new joint venture, known as Southwest Specialty Eggs, will acquire the Egg-Landís Best, franchise for the state of Arizona with exclusive licensing agreements for the sale of Egg-Landís Best and Land Oí Lakes branded specialty eggs and other premium brands. Sales of Egg-Landís Best specialty eggs accounted for approximately 14.3% of Cal-Maineís total shell egg sales in fiscal 2013.
08:28 EDTHLFHerbalife confirms Alan Hoffman as EVP of global corporate affairs
Subscribe for More Information
07:29 EDTPFEEMA recommends indication for Ecalta to treat invasive candidiasis
The Committee for Medicinal Products for Human Use adopted a positive opinion recommending a variation to the terms of the marketing authorization for the medicinal product Ecalta, offered by Pfizer. The CHMP adopted a change to an indication as follows: "Treatment of invasive candidiasis in adult patients."
07:27 EDTBMYEMA recommends expanded indication for Baraclude
Subscribe for More Information
07:11 EDTHLFHerbalife hires VP's former chief of staff to help fight Ackman, NY Post says
Herbalife, which is under continued attack from investor Bill Ackman and being investigated by the FTC, is hiring Alan Hoffman, Vice President Joe Bidenís former chief of staff, to "fight back against Bill Ackmanís multi-front efforts ó both here on Capitol Hill, with federal regulators, and now state AGs all across the states,Ē said The New York Post, citing a Washington insider. Reference Link
06:00 EDTBMYBristol-Myers implied volatility of 17 at lower end of index mean range
Subscribe for More Information
July 24, 2014
11:22 EDTBMYBristol-Myers says considering different sizes of deal opportunities
Subscribe for More Information
10:57 EDTBMYBristol-Myers says M&A would have to be good strategic fit
Subscribe for More Information
10:48 EDTBMYBristol-Myers says guidance assumes R&D credit will be extended
Says Reyataz seeing increased competitive pressure. Says business development a top priority for capital allocation. Comments made on the Q2 earnings conference call.
08:30 EDTCGCarlyle may be last firm in rigging suit as peers near settlement, NY Post says
Carlyle Group (CG) may soon be the only private equity firm left to settle a suit that accused it and several of its peers of conspiring to hold down deal prices and one source close to the situation said ďmy expectation is there will be a trial,Ē according to The New York Post. Bain Capital, Silver Lake and Goldman Sachs (GS) previously settled for a combined $150.5M and KKR (KKR), Blackstone (BX) and TPG Capital are expected to settle for an amount above that "within days," the report said. Reference Link
08:28 EDTBMYBristol-Myers management to meet with JPMorgan
Subscribe for More Information
07:32 EDTBMYBristol-Myers reaffirms 2014 EPS outlook $1.70-$1.80, consensus $1.77
Subscribe for More Information
07:31 EDTBMYBristol-Myers reports Q2 EPS 48c, consensus 44c
Reports Q2 revenue $ $3.89B, consensus $3.85B.
05:26 EDTBMYBristol-Myers, Ono Pharmaceutical announces strategic collaboration in Japan
Bristol-Myers Squibb and Ono Pharmaceutical have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan. As part of the agreement, Bristol-Myers Squibb and Ono will jointly develop and commercialize Opdivo and Yervoy across a broad range of tumor types. Bristol-Myers Squibb and Ono will jointly pursue development of monotherapy and combination regimens, with Opdivo as the foundational therapy in Japan, South Korea and Taiwan, and leverage global clinical trials by including patients from the three countries.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use